Pre-market Portfolio Digest
* As of Mon, Mar 27, 2023 08:22 ET Portfolio Health Check
| Score Your rating score is 3.28 / 5.0  | Breakdown Strong Buy: 1 stock Buy: 3 stocks Hold: 21 stocks Sell: 2 stocks Strong Sell: 0 stocks |
Yesterday's Performance
| Top Gainers | Top Losers |
| FE: +3.76% | DE: -1.37% |
| AGR: +3.2% | AA: -0.37% |
| DUK: +3.08% |
FEATURED: Go Premium for $4.95 for your first 30 days
Get the bull and bear perspective on 1000s of stocks with Seeking Alpha's diverse pool of contributors and community debate. Join Premium for only $4.95 for your first 30 days.
Analysis
 | AT&T: Why Isn't Anyone Talking About This? Quad 7 Capital • T |
 | Bristol Myers Squibb: Unraveling The Complexities Of Valuation Bashar Issa • BMY |
 | Viatris: The Value And The Value Trap Trapping Value • VTRS |
 | AT&T: Are Your Dividends Safe? Bohdan Kucheriavyi • T |
Related Analysis
 | Pyxis Oncology: Cashed Up And Entering The Clinic Biotech Beast • PFE |
 | MDA Breakout Stocks/ETFs Week 13 - March 2023: High-Frequency Gainers To Give You An Edge JD Henning • PG |
 | 10 Dividend Growth Stocks - March 2023 FerdiS • BMY • PFE |
Download the Seeking Alpha App!
Want More Investing Ideas Newsletters?
This email was sent to you because you signed up to receive Pre-Market Portfolio Digest. If you do not want to receive Delacrox Portfolio Digest emails, click here to unsubscribe.
If you believe this has been sent to you in error, please safely unsubscribe.
